Page last updated: 2024-10-27

fluorouracil and Dysgeusia

fluorouracil has been researched along with Dysgeusia in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.

Research Excerpts

ExcerptRelevanceReference
" The most common side effect of this medication is localized irritant dermatitis."1.37Metallic taste as a side effect of topical fluorouracil use. ( Han, SY; Youker, S, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basset-Seguin, N1
Han, SY1
Youker, S1

Reviews

1 review available for fluorouracil and Dysgeusia

ArticleYear
    Annales de dermatologie et de venereologie, 2018, Volume: 145 Suppl 5

    Topics: Alopecia; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Basal Cel

2018

Other Studies

1 other study available for fluorouracil and Dysgeusia

ArticleYear
Metallic taste as a side effect of topical fluorouracil use.
    Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:10

    Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous C

2011